Skip to main content

Advertisement

SpringerLink
Log in

Intraductal Papillary Mucinous Neoplasms of the Pancreas: Making a Disposition Using the Natural History

  • Pancreas (CE Forsmark, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

The process of Intraductal papillary mucinous neoplasms (IPMN) follows the adenoma-to-carcinoma sequence. If it progresses to malignancy about 5 years is required. Even though the process is slow IPMN provides the clinician with the opportunity to avoid malignancy if the patient is at risk. The natural history as observed through Kaplan Meier event curves for occurrence of malignancy show the process to malignancy is much faster (50% within 2 years) if pancreatitis-like symptoms are present or if the main pancreatic duct (MPD) is involved. Almost all decisions to resect (95% in our experience) are based on the presence of symptoms or the MPD location. Cyst size is used infrequently. Every patient with an IPMN should always have a planned follow-up and the frequency depends on the perceived risk of malignancy—immediate imaging if becomes symptomatic to every 2 to 3 years if asymptomatic side branch lesions. The natural history provides modern guidelines for making decisions in patients with a newly discovered IPMN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Zamboni G, Scarpa A, Bogina G, Iacono C, Bassi C, Talamini G, Sessa F, Capella C, Solcia E, Rickaert F, Mariuzzi GM, Klöppel G. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999;23:410–22.

    Article  PubMed  CAS  Google Scholar 

  2. Longnecker DS, Adler G, Hruban RH, Klöppel G. Intraductal papillary-mucinous neoplasms of the pancreas. In Hamilton SR, Aaltonen LA (eds): World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Digestive System. Lyon, France: IARC Press, 2000, pp 237–241.

  3. Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH. World health organization international classification of tumours. Histological typing of tumours of the exocrine pancreas. Germany: Springer-Verlag Berlin Heidelberg; 1996. p. 1–61.

    Book  Google Scholar 

  4. Klöppel G, Luttges J. WHO-classification 2000: exocrine pancreatic tumors. Verh Dtsch Ges Pathol. 2001;85:219–28.

    PubMed  Google Scholar 

  5. Hashimoto Y, Traverso LW. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a web-based calculator to improve homogeneity of definition. Surgery. 2010;147:503–15.

    Article  PubMed  Google Scholar 

  6. Traverso LW, Kozarek RA. Diagnosis and Natural History of Intraductal Papillary Mucinous Neoplasms. In: Beger HG, Büchler MW, Kozarek RA, Lerch MM, Neoptolemos JP, Shiratori K, Warshaw AL, Whitcomb DC, Rau BM, editors. The pancreas: An integrated textbook of basic science, medicine, and surgery. 2nd ed. Malden, MA: Blackwell Publishing; 2008. p. 918–23.

    Google Scholar 

  7. Paye F, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery. 2000;127:536–44.

    Article  PubMed  CAS  Google Scholar 

  8. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-Duct intraductal papillary mucinous neoplasms of the pancreas: Clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678–87.

    Article  PubMed  Google Scholar 

  9. • Suzuki Y, Atomi Y, Sugiyama M et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 2004; 28:241–246. This Japanese cooperative series of over 1000 cases supports the adenoma to carcinoma sequence and that it takes about 5 years.

    Article  PubMed  Google Scholar 

  10. Jang JY, Kim SW, Ahn YJ, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005;12:124–32.

    Article  PubMed  Google Scholar 

  11. Okabayashi T, Kobayashi M, Nishimori I, et al. Clinicopathological features and medical management of intraductal papillary mucinous neoplasms. J Gastroenterol Hepatol. 2006;21:462–7.

    Article  PubMed  Google Scholar 

  12. Shyr YM, Su CH, Tsay SH, Lui WY. Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms. Ann Surg. 1996;223:141–6.

    Article  PubMed  CAS  Google Scholar 

  13. • Tanaka M, Chari S, Adsay V, Fernandez-delcastillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17–32. The consensus criteria for resection were first published here based on the reference 9. These criteria will help make a decision to resect in 95% of cases.

    Article  PubMed  Google Scholar 

  14. • Moriya T, Hashimoto Y, Traverso LW. The duration of symptoms predicts the presence of malignancy in 210 resected cases of pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg 2010; 2011:762–770. The visual depiction of the natural history in this study shows that the rate of occurrence of malignancy is much sooner with lesions that are symptomatic or involve the main pancreatic duct.

    Google Scholar 

  15. Levy P, Jouannaud V, O’Toole D, Couvelard A, Vullierme MP, Palazzo L, Aubert A, Ponsot P, Sauvanet A, Maire F, Hentic O, Hammel P, Ruszniewski P. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol. 2006;4:460–8.

    Article  PubMed  Google Scholar 

  16. • Moriya T, Traverso LW. Fate of the pancreatic remnant after resection for intraductal papillary mucinous neoplasm—A Level II Cohort study. Arch Surg (in press). This Level II cohort study show that after long term follow-up the remaining pancreas will develop a new lesion in about 1 of 10 cases over 4 years and the lesion will most likely be benign if the original was benign. It supports parenchymal preservation as new lesions were not associated with the histology of the surgical margin.

  17. Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G, Bernades P, Belghiti J, Ruszniewski P, Flejou JF. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Center for Pancreatic Disease, St. Luke’s Health Care System, 100 East Idaho St., #301, Boise, ID, 83712, USA

    L. William Traverso, Toshiyuki Moriya & Yasushi Hashimoto

Authors
  1. L. William Traverso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshiyuki Moriya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasushi Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. William Traverso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Traverso, L.W., Moriya, T. & Hashimoto, Y. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Making a Disposition Using the Natural History. Curr Gastroenterol Rep 14, 106–111 (2012). https://doi.org/10.1007/s11894-012-0239-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-012-0239-7

Keywords

Search

Navigation